Although smoking remains the main cause of lung cancer for most of the patients but there are other factors as well which may cause lung cancer. Non-smokers are also being getting trapped…
Tag: Treatment of Lung Cancer
Ramucirumab Injection in Combination with Erlotinib Gets FDA Approval for NSCLC
The Food and Drug Administration (FDA) has approved a 10mg/mL solution for first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) harboring EGFR exon 19 deletions or exon 21 mutations….
FDA Approves Tabrecta, First Targeted Therapy for NSCLC
The FDA has approved Tabrecta, Novartis for the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. NSCLC is the most common type of lung…
Tackling Coronavirus during Lung Cancer Treatment
At the end of year 2019, a novel coronavirus was identified in Wuhan, a city in the Hubei Province of China. It spread rapidly and resulted in an increasing number of cases…
What to Consider Before Getting A Lung Cancer on Marijuana Medication?
Lung cancer is one of the major causes of death, particularly in the US. It has been found that more people die because of it as compared to other types of cancers….
Yale Cancer Center Study Shows Long-Term Survival Benefits for Lung Cancer Patients
As per the global study led by Yale Cancer Center, a tiny amount of biomarker known as PD-L1 can predict long-term survival benefits from pembrolizumab. Pembrolizumab (Keytruda) is one of the first…
Obesity May Boost Effectiveness of Lung Cancer Treatment, According to Study
The latest study in the field of lung cancer has revealed that an immune system-based treatment for lung cancer, worked better in people who were overweight in some trials. In the medical…
Lung Cancer Screenings Could Detect Signs of Heart Disease via Artificial Intelligence
According to a study presented at the annual meeting of the Radiological Society of North America, artificial intelligence could measure a common marker of heart disease in patients getting chest CT scans…